Teacher Retirement System of Texas cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 41.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,179 shares of the medical research company’s stock after selling 101,850 shares during the period. Teacher Retirement System of Texas’ holdings in Thermo Fisher Scientific were worth $27,756,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Thermo Fisher Scientific by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock worth $4,640,970,000 after buying an additional 629,093 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Thermo Fisher Scientific by 1.6% during the 2nd quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock worth $4,074,828,000 after buying an additional 366,584 shares in the last quarter. Capital Research Global Investors boosted its holdings in shares of Thermo Fisher Scientific by 29.8% during the 2nd quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock worth $3,019,185,000 after buying an additional 3,973,136 shares in the last quarter. Capital World Investors boosted its holdings in shares of Thermo Fisher Scientific by 6.1% during the 2nd quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock worth $2,051,721,000 after buying an additional 671,637 shares in the last quarter. Finally, Longview Partners Guernsey LTD boosted its holdings in shares of Thermo Fisher Scientific by 7.4% during the 3rd quarter. Longview Partners Guernsey LTD now owns 4,564,913 shares of the medical research company’s stock worth $863,682,000 after buying an additional 313,782 shares in the last quarter. Institutional investors and hedge funds own 86.31% of the company’s stock.

A number of research firms have issued reports on TMO. ValuEngine upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Bank of America increased their price target on Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Morgan Stanley increased their price target on Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Barclays increased their price target on Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Finally, Leerink Swann restated an “outperform” rating and set a $239.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Thursday, February 1st. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $220.50.

In related news, SVP Gregory J. Herrema sold 33,327 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $219.70, for a total value of $7,321,941.90. Following the completion of the sale, the senior vice president now directly owns 60,471 shares of the company’s stock, valued at approximately $13,285,478.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The disclosure for this sale can be found here. Insiders have sold 144,327 shares of company stock worth $28,680,042 over the last ninety days. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $198.73 on Friday. The company has a current ratio of 1.35, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 12-month low of $151.74 and a 12-month high of $226.44. The firm has a market capitalization of $83,226.59, a P/E ratio of 35.49, a PEG ratio of 1.52 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping analysts’ consensus estimates of $2.66 by $0.13. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. During the same period in the prior year, the firm earned $2.41 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 22.1% on a year-over-year basis. research analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.34%. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.71%.

ILLEGAL ACTIVITY WARNING: “Teacher Retirement System of Texas Has $27.76 Million Position in Thermo Fisher Scientific Inc. (TMO)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/02/09/teacher-retirement-system-of-texas-has-27-76-million-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.